Companies and countries are focused on PR as they jostle to gain the green advantage
Cellarity Raises $123 Million in Series B Funding to Pioneer a New Approach to Drug Discovery, Treating Disease at the Level of the Cell as Opposed to a Single Molecular Target
Synova scores 4.5x on sale of Fairstone to TA
